Status:
COMPLETED
Tryptophan and Behavior Therapy for Cocaine Abuse - 1
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Collaborating Sponsors:
Johns Hopkins University
Conditions:
Cocaine-Related Disorders
Eligibility:
All Genders
18-55 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to assess the efficacy of tryptophan vs. placebo, and voucher payments vs. a control condition, in the treatment of cocaine dependence.
Detailed Description
This clinical trial uses a 2 by 2 design to compare tryptophan to placebo, and voucher incentives vs. a control condition, in the outpatient treatment of cocaine dependence- using a relapse prevention...
Eligibility Criteria
Inclusion Criteria:
- Cocaine dependent
Exclusion Criteria:
- Physically dependent on drugs of abuse other than cocaine
- Significant medical or psychiatric illness (besides substance abuse disorder)
- Pregnant
Key Trial Info
Start Date :
March 1 1997
Trial Type :
INTERVENTIONAL
End Date :
April 1 2001
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00000324
Start Date
March 1 1997
End Date
April 1 2001
Last Update
January 12 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States, 21224